People should receive clear, balanced information and have enough time to make a voluntary decision.
QAZIIM · Equity & safety
Safe care and fair access are fundamental
Advanced medicine earns trust when risks are managed carefully, access is fair and every person is treated with dignity and respect.
01
Equity and safety must be built into every service, study and decision
Genomic and digital medicine can create important benefits, but they can also create new risks and widen existing inequalities. QAZIIM addresses these challenges through informed consent, clinical validation, privacy protection, independent oversight and services that consider language, geography, disability and affordability.
Health and genomic data must be protected, accessed only when justified and used for clearly defined purposes.
Services should be understandable and accessible to people with different languages, circumstances and healthcare needs.
Assess clinical, ethical, privacy and access concerns before work begins.
Use consent, quality systems, secure data practices and independent review.
Track safety, quality, outcomes and unintended consequences.
Respond transparently when a problem is identified and strengthen the system.
Core safeguards
- Independent ethical review for research involving people, biological materials or identifiable data
- Clinical validation before a result is used to guide patient care
- Meaningful human oversight of decisions supported by artificial intelligence
- Respectful communication and service in Kazakh, Russian and English